Business Pill Intended to Be Covid-19’s Tamiflu Succeeds in Key Study Dustin Moskovitz Oct 1, 2021 0 Merck MRK 0.03% & Co. and its partner Ridgeback Biotherapeutics LP said their experimental Covid-19 pill helped prevent high-risk…